PL321779A1 - Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis - Google Patents

Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis

Info

Publication number
PL321779A1
PL321779A1 PL96321779A PL32177996A PL321779A1 PL 321779 A1 PL321779 A1 PL 321779A1 PL 96321779 A PL96321779 A PL 96321779A PL 32177996 A PL32177996 A PL 32177996A PL 321779 A1 PL321779 A1 PL 321779A1
Authority
PL
Poland
Prior art keywords
secsual
kinetosis
obsessive
vomiting
therapy
Prior art date
Application number
PL96321779A
Other languages
English (en)
Inventor
Constansa Jordi Frigola
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of PL321779A1 publication Critical patent/PL321779A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL96321779A 1995-12-12 1996-12-11 Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis PL321779A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9514690A FR2742052B1 (fr) 1995-12-12 1995-12-12 Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports
PCT/EP1996/005736 WO1997021439A1 (fr) 1995-12-12 1996-12-11 Medicament destine au traitement des troubles obsessifs compulsifs, de l'apnee du sommeil, des dysfonctions sexuelles, de l'emese et du mal des transports

Publications (1)

Publication Number Publication Date
PL321779A1 true PL321779A1 (en) 1997-12-22

Family

ID=9485400

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96321779A PL321779A1 (en) 1995-12-12 1996-12-11 Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis

Country Status (16)

Country Link
EP (1) EP0808166A1 (no)
JP (1) JPH11501051A (no)
CN (1) CN1177297A (no)
AR (1) AR004378A1 (no)
AU (1) AU716665B2 (no)
CA (1) CA2211161A1 (no)
CZ (1) CZ255197A3 (no)
ES (1) ES2134709B1 (no)
FR (1) FR2742052B1 (no)
HU (1) HUP9800198A2 (no)
IL (1) IL121461A0 (no)
NO (1) NO973589L (no)
PL (1) PL321779A1 (no)
TR (1) TR199700794T1 (no)
WO (1) WO1997021439A1 (no)
ZA (1) ZA9610457B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763950B1 (fr) * 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
WO2002014314A2 (en) 2000-08-14 2002-02-21 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
NZ524192A (en) 2000-08-14 2005-02-25 Ortho Mcneil Pharm Inc Substituted pyrazoles
US6953793B2 (en) 2000-08-14 2005-10-11 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazoles
WO2002020002A2 (en) 2000-09-06 2002-03-14 Ortho Mcneil Pharmaceutical, Inc. A method for treating allergies
WO2005030148A2 (en) 2003-09-25 2005-04-07 Cenomed, Inc. Tetrahydroindolone derivatives for treatment of neurological conditions
WO2005094827A1 (en) * 2004-03-30 2005-10-13 Kestrel Pharmaceuticals Inc. Methods for treating sexual dysfunction
CA2606471C (en) * 2005-04-26 2014-02-11 Hypnion, Inc. Benzisoxazole piperidine compounds and methods of use thereof
WO2006116615A1 (en) 2005-04-26 2006-11-02 Hypnion, Inc. Benzisoxazole piperazine compounds and methods of use thereof
GB2435827A (en) * 2006-03-09 2007-09-12 Del Dr Esteve S A Spain Lab Use of substituted piperazine compounds for the treatment of food related disorders
CN115304590B (zh) * 2022-09-19 2024-05-28 皮摩尔新药(辽宁)有限公司 2h-苯并三氮唑衍生物及其制备方法及含有它们的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles

Also Published As

Publication number Publication date
CN1177297A (zh) 1998-03-25
IL121461A0 (en) 1998-02-08
CZ255197A3 (cs) 1998-01-14
CA2211161A1 (fr) 1997-06-19
ZA9610457B (en) 1997-06-24
FR2742052A1 (fr) 1997-06-13
JPH11501051A (ja) 1999-01-26
NO973589D0 (no) 1997-08-04
TR199700794T1 (xx) 1997-11-21
NO973589L (no) 1997-10-08
MX9706133A (es) 1997-11-29
HUP9800198A2 (hu) 1999-09-28
AU1376497A (en) 1997-07-03
AR004378A1 (es) 1998-11-04
EP0808166A1 (fr) 1997-11-26
WO1997021439A1 (fr) 1997-06-19
ES2134709A1 (es) 1999-10-01
ES2134709B1 (es) 2000-05-16
FR2742052B1 (fr) 1998-04-10
AU716665B2 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
IL187512A0 (en) Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
HUP0100069A3 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
AU5200498A (en) Improved methods and devices for the treatment of airway obstruction, sleep apnea and snoring
HK1026141A1 (en) Treatment of sleep apnea.
AU6897198A (en) Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
HUP0004439A3 (en) 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
AU3497295A (en) Compositions and methods for the treatment of body weight disorders, including obesity
AU3309097A (en) Reduction of skin sensitization in electrotransport drug delivery
AU2604301A (en) Tnf inhibitors for the treatment of neurological, retinal and muscular disorders
PL321779A1 (en) Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis
AU6406996A (en) Compositions for the treatment and diagnosis of body weight disorders, including obesity
HUP9900028A3 (en) Pharmaceutically active quinazoline compounds, their production, use thereof and medicament containing them
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
NZ513650A (en) Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo
LT97135A (en) Use of melatonin in the manufacture of a medicament for treating patients suffering from drug addiction
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
ZA200107143B (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders.
HUP9904294A3 (en) Topiramate derivatives and their use for producing medicament useful in the treatment of neuropathic pain
EP0858340A4 (en) COMBINATION THERAPY FOR TREATING DIABETES AND OBESITY
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
WO1997005864A3 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
AU5386700A (en) A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases
AU9633998A (en) Sanitary treatment of a sleeping mattress and associated device